Industry, Policy and Access Pathways

The state of the psychedelic industry and policy

About this session

This presentation provides a look at the state of the psychedelics industry, with a focus on drug development and policy. Beyond simply offering a precise of developments in this realm, it also delves into some of the key questions and tensions that the commercialisation of psychedelics - and the attendant incentive structures - raise. It finishes by pointing to potential futures and things to watch.

Presenter
Photo of Josh Hardman

Josh Hardman

Founder and Editor

Psychedelic Alpha